Mechanisms of cancer stem cells drug resistance and the pivotal role of HMGA2

Pathol Res Pract. 2022 Jun:234:153906. doi: 10.1016/j.prp.2022.153906. Epub 2022 Apr 19.

Abstract

Nowadays, the focus of researchers is on perceiving the heterogeneity observed in a tumor. The researchers studied the role of a specific subset of cancer cells with high resistance to traditional treatments, recurrence, and unregulated metastasis. This small population of tumor cells that have stem-cell-like specifications was named Cancer Stem Cells (CSCs). The unique features that distinguish this type of cancer cell are self-renewing, generating clones of the tumor, plasticity, recurrence, and resistance to therapies. There are various mechanisms that contribute to the drug resistance of CSCs, such as CSCs markers, Epithelial mesenchymal transition, hypoxia, other cells, inflammation, and signaling pathways. Recent investigations have revealed the primary role of HMGA2 in the development and invasion of cancer cells. Importantly, HMGA2 also plays a key role in resistance to treatment through their function in the drug resistance mechanisms of CSCs and challenge it. Therefore, a deep understanding of this issue can provide a clearer perspective for researchers in the face of this problem.

Keywords: Cancer stem cells; Chemo-resistance; Drug resistance; HMGA2.

Publication types

  • Review

MeSH terms

  • Drug Resistance, Neoplasm
  • Epithelial-Mesenchymal Transition
  • Humans
  • Neoplasms* / pathology
  • Neoplastic Stem Cells* / pathology
  • Signal Transduction